A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Source:http://linkedlifedata.com/resource/pubmed/id/16566626

Download in:

View as

General Info

PMID
16566626